Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
AD     Remove this Ad

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.9620.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 21.96 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,873.3 Cr -0.5% -10.4% -11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹100,056.0 Cr -5.7% -7.8% -13.2% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-0.5%

-10.4%

-11.4%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses